Anticoagulant Use in High Stroke-Risk Patients With Nonvalvular Atrial Fibrillation.
- Author(s): Nguyen, Hannah K
- Humber, Douglas
- Checkoway, Harvey
- Blanchard, Daniel
- Watanabe, Jonathan H
- et al.
Published Web Locationhttps://doi.org/10.4140/tcp.n.2018.521
Background Oral anticoagulants (OACs) are recommended for nonvalvular atrial fibrillation (NVAF) patients with moderate-to high-stroke risk. Objective To examine nationally reflective OAC usage in incident NVAF patients longitudinally. Design Three-year retrospective cohort analysis. Setting Medicare Part D recipients in the contiguous United States.